Fierce Pharma

DECEMBER 1, 2023

Turkish authorities have launched an investigation into 19 pharmaceutical companies to probe whether their operations violated the country’s competition law, the Turkish Competition Authority discl | The companies, which include Pfizer, J&J, Sanofi, AbbVie, AstraZeneca, Merck and others are being probed for potentially violating Turkish competition law, according to a release from the country's government.

Competition 241

Competition Government Pharmaceutical 241

MedCity News

DECEMBER 1, 2023

At RSNA 2023, Nvidia launched new set of cloud-based APIs designed to speed up the creation and deployment of specialized AI models in the medical imaging field. The new offering is a cloud-native extension to Nvidia’s Monai framework, which is its open-source framework for medical imaging AI.

Medical 127

Medical Specialization Healthcare Healthcare 127

Fierce Pharma

DECEMBER 1, 2023

After a hard-fought battle for FDA approval, AstraZeneca has hit another setback on its quest to turn its potassium-reduction drug Lokelma into a blockbuster. | AstraZeneca has put the kibosh on two late-stage Lokelma trials testing the hyperkalemia drug in patients with heart and kidney diseases. The studies were called off due to “substantially increased enrollment times and low event rates,” AZ said Friday.

FDA 231

FDA Pharma Patients 231

MedCity News

DECEMBER 1, 2023

The Patient-Centered Outcomes Research Institute announced that it is funding four studies focused on reducing maternal health inequities. The studies all leverage partnerships with community organizations.

Patients 121

Patients 121

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

DECEMBER 1, 2023

Texas attorney general Ken Paxton is going after Pfizer—again. | Texas attorney general Ken Paxton is going after Pfizer—again. Less than two weeks after documents were unsealed showing that Texas has accused Pfizer and manufacturer Tris Pharma of providing a compromised ADHD medicine to the state, Paxton has sued Pfizer for “unlawfully misrepresenting the effectiveness” of the company’s COVID-19 vaccine.

Manufacturing 224

Manufacturing Medicine Pharma 224

European Pharmaceutical Review

DECEMBER 1, 2023

AbbVie has agreed to acquire ImmunoGen and its first-in-class antibody-drug conjugate (ADC) ELAHERE ® (mirvetuximab soravtansine-gynx), for a total of approximately $10.1 billion. The antibody-drug conjugate is the first to be approved for platinum-resistant ovarian cancer (PROC) and show meaningful survival benefit for this form of the disease. As a folate receptor alpha (FRα) with a maytansinoid payload DM4, a potent tubulin inhibitor, the biologic medicine offers expansion opportunities in e

Food and Drug Administration 116

Food and Drug Administration Marketing FDA Food 116

PharmExec

DECEMBER 1, 2023

Artificial intelligence is making it quicker to get drug candidates to the clinic, but it isn’t addressing the fundamental need to marry the right candidate and the right target to the right disease.

115

115

Pharmaceutical Commerce

DECEMBER 1, 2023

In clinical trials, Keytruda plus Padcev lowered the risk of disease progression or death by 55% compared with chemotherapy in adult patients with locally advanced or metastatic urothelial carcinoma.

FDA 110

FDA Patients 110

Eversana Intouch

DECEMBER 1, 2023

Recently, Ad Forum published an article highlighting five campaigns it found to be “ Raising the Bar for Health Equity in Advertising.” One was our ongoing work with The Chrysalis Initiative, a nonprofit working to eliminate racial disparities in breast cancer treatment. This alliance dates back to 2021, but in 2023, as Fierce Pharma put it, we “ roared back from rejection to craft a Cannes-winning campaign hospitals couldn’t ignore.

Pharma 105

Pharma Management Leads Marketing 105

MedCity News

DECEMBER 1, 2023

Practices should take a fresh look at their coding quality, which can help reduce denials, payer takebacks, and cash flow issues. Implementing intensive coding training, CAC technology, and internal audit and review programs can help. However, for practices that lack the resources to make such investments, outsourcing may be a better approach.

Training 104

Training Physicians Medical 104

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

European Pharmaceutical Review

DECEMBER 1, 2023

Since its introduction in 1980, capillary electrophoresis (CE) has been one of the most powerful techniques applicable as a choice method in the biopharmaceutical industry for the characterisation and quality control (QC) testing of biomolecules such as proteins, peptides as well as monoclonal antibodies (mAbs) and high molecular weight polysaccharides. 1 In addition to the intrinsic advantages of CE, such as high separation efficiency, high resolution, low sample volume requirements, short sepa

Pharmaceutical 98

Pharmaceutical 98

MedCity News

DECEMBER 1, 2023

As a heart transplant recipient less than three years out from quadruple organ failure, and a father of two young children, I’m not just hoping that modernization will save and extend more lives. I’m counting on it.

104

104

European Pharmaceutical Review

DECEMBER 1, 2023

A new report by the Committee of Experts on minimising the public health risks posed by falsified medical products and related crimes (CD-P-PH/CMED) shares insight on how authorities perceive and address the falsification of medical devices. The report details findings from survey completed by 21 of the 46 Council of Europe member states on counterfeit medical devices.

Medical 98

Medical Pharmaceutical 98

MedCity News

DECEMBER 1, 2023

Laying AI functions on top of already outdated systems or relying on separate solutions that do not play into the unified stack system––especially given the volume of data, delicate privacy issues and the need for constant updates––does not optimally contribute to the advancement of radiology.

Medical 104

Medical 104

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

European Pharmaceutical Review

DECEMBER 1, 2023

During CPHI Barcelona, EPR Editor Caroline Peachey asked Anil Kane, Global Head of Technical & Scientific Affairs, Pharma Services, at Thermo Fisher Scientific about the dynamic landscape of pharmaceutical drug development. Dr Kane leads a team of subject matter experts at Thermo Fisher, covering drug products in both sterile injectable dosage and oral solid dosage forms.

Food and Drug Administration 98

Food and Drug Administration Manufacturing Pharma Patients 98

MedCity News

DECEMBER 1, 2023

We should strive for a future where patients have easy and affordable access to medications, supported on their journey by trusted pharmacy professionals who are an integral part of their care team.

Patients 105

Patients Medical 105

Referral MD

DECEMBER 1, 2023

Managing dental referrals can be tedious, involving phone calls, emails, and endless paperwork. Dental referral software offers a comprehensive solution by digitizing the entire process. You can send and receive referrals, track their progress, and easily communicate with other dental practices with just a few clicks. Say goodbye to lost referrals and hello to a more organized and efficient workflow!

Marketing 94

Marketing Patients Engineering Media 94

Pharmaceutical Technology

DECEMBER 1, 2023

Hot on the heels of the designation, Orchard Therapeutics is pressing ahead with a multi-centre trial for the candidate with a start date in December.

FDA 98

FDA 98

Advertisement

MedCity News

DECEMBER 1, 2023

It is only by supporting the public health workers, and making their jobs more appealing that health agencies can strengthen the workforce to prevent and respond to future public health threats.

Training 91

Training 91

pharmaphorum

DECEMBER 1, 2023

AstraZeneca has decided to abandon two phase 3 trials of its drug to reduce high levels of potassium in the blood (hyperkalaemia) – Lokelma – in patients with kidney disease. The STABILIZE-CKD and DIALIZE-Outcomes studies – part of AZ’s CRYSTALIZE programme for the drug – have been shelved because patients were being enrolled into them more slowly than hoped for, and clinical events were occurring at a lower rate than expected.

Patients 105

Patients 105

Pharmaceutical Technology

DECEMBER 1, 2023

The SMC and NICE have recommended the use of AstraZeneca’s durvalumab to treat advanced biliary tract cancers in England and Scotland.

97

97

PharmaTimes

DECEMBER 1, 2023

Every year, over 44,000 men are diagnosed with prostate cancer in England - News - PharmaTimes

Patients 115

Patients 115

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

Pharmaceutical Technology

DECEMBER 1, 2023

Biocon subsidiary Biocon Biologics has successfully integrated Viatris' biosimilars business in 31 countries in Europe.

98

98

PharmaTimes

DECEMBER 1, 2023

Every year, around 55,000 women in the UK are diagnosed with the condition - News - PharmaTimes

Patients 106

Patients 106

Pharmaceutical Technology

DECEMBER 1, 2023

Partnership deals involving psychedelic drugs saw a 500% growth in total deal volume from 2019 to 2023 year-to-date (YTD).

98

98

PharmExec

DECEMBER 1, 2023

How to build a loyal audience of brand evangelists.

Media 115

Media Healthcare Healthcare 115

Advertisement

Distribution

pharmaphorum

DECEMBER 1, 2023

FDA starts review of Padcev/Keytruda for bladder cancer Phil.

FDA 119

FDA 119

PharmExec

DECEMBER 1, 2023

The FDA previously granted accelerated approval to the Keytruda plus Padcev combination for the treatment of patients with locally advanced or metastatic urothelial carcinoma who are ineligible for cisplatin-containing chemotherapy.

FDA 59

FDA Patients 59

MedCity News

DECEMBER 1, 2023

NODE.Health 7th annual conference. December 6-8, 2023, Microsoft NYC, New York.

Medicine 95

Medicine 95

pharmaphorum

DECEMBER 1, 2023

MSD, Amgen back patient data specialist Culmination Bio Phil.

Patients 105

Patients 105

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales